The main office of represented VC is situated in the Wellesley. The venture was found in North America in United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Bioventures Investors, startups are often financed by DSM Venturing, BASF Venture Capital, Techno Venture Management. The meaningful sponsors for the fund in investment in the same round are Lilly Ventures, Oxford Bioscience Partners, Advanced Technology Ventures. In the next rounds fund is usually obtained by Lilly Ventures, Polaris Partners, Oxford Bioscience Partners.
We can highlight the next thriving fund investment areas, such as Biotechnology, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Biolex Therapeutics, Ardais Corporation, Verax Biomedical. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.
Speaking about the real fund results, this VC is 1 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Bioventures Investors performs on 6 percentage points less the average number of lead investments. The top amount of exits for fund were in 2005. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The fund is constantly included in less than 2 deals per year.
The fund was created by Marc Goldberg. Besides them, we counted 6 critical employees of this fund in our database.
Funds with similar focus
|Amuse||Japan, Kanagawa Prefecture, Kawasaki|
|Avnatar||Florida, Naples, United States|
|Baliopharm||Germany, Nordrhein-Westfalen, North Rhine-Westphalia|
|Beijing Financial Street Capital Operation Center||Beijing, Beijing, China|
|C31Ventures||Central, Central Region, Singapore|
|Dai-Ichi Hoki||Japan, Tokyo|
|Guangzhou Nansha Financial Holding||-|
|Matahari Department Stores (MDS)||Banten, Indonesia, Jawa Barat|
|Millennium Technology Value Partners||New York, New York, United States|
|Moxxie Ventures||California, San Francisco, United States|
|MXC Capital||England, London, United Kingdom|
|Redmont Venture Partners||Alabama, United States, Vestavia Hills|
|Shadow Ventures||Atlanta, Georgia, United States|
|Sparebanken Vest||New Jersey, North Bergen, United States|
|Swiss Immo Lab||Switzerland, Zürich, Zurich|
|Zlvision Tech||China, Qingdao Shi, Shandong|
|$23M||08 Dec 2020||Richmond, Virginia, United States|
|$10M||12 Nov 2019||South San Francisco, California, United States|
|$17M||26 Nov 2018||Jiangsu|
|$70M||14 Sep 2018||Illinois, United States|
Unified Information Devices
|$2M||10 Jul 2018||Illinois, United States|
|$2M||16 Mar 2017||Salt Lake City, Utah, United States|
POC Medical Systems
|$21M||10 Jan 2017||California, United States|
|$37M||05 Jul 2016||Illinois, United States|
|01 Jan 2015||Jiangsu|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.